-+ 0.00%
-+ 0.00%
-+ 0.00%

ABBVIE SUBMITS BIOLOGICS LICENSE APPLICATION (BLA) FOR ETENTAMIG TO U.S. FDA FOR ADULTS LIVING WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Reuters·10/27/2026 12:03:51